高强度聚焦超声 (HIFU) 对前列腺癌肿瘤特异性免疫反应的影响。

IF 0.6 4区 医学 Q4 UROLOGY & NEPHROLOGY
Wei Chen, Lina He, Haoran Huang, Xiang Zeng, Guangqing Fu, Yi Liu, Yong Liang
{"title":"高强度聚焦超声 (HIFU) 对前列腺癌肿瘤特异性免疫反应的影响。","authors":"Wei Chen, Lina He, Haoran Huang, Xiang Zeng, Guangqing Fu, Yi Liu, Yong Liang","doi":"10.56434/j.arch.esp.urol.20247704.44","DOIUrl":null,"url":null,"abstract":"<p><p>High intensity focused ultrasound (HIFU), also referred to as focused ultrasound surgery (FUS), has garnered recent attention as a non-invasive therapeutic strategy for prostate cancer. It utilizes focused acoustic energy to achieve localized thermal ablation, while also potentially exerting immunomodulatory effects. This review aims to elucidate the mechanisms underlying how HIFU influences tumor-specific immune responses in prostate cancer. These mechanisms include the release of tumor-associated antigens and damage-associated molecular patterns, the activation of innate immune cells, the facilitation of antigen presentation to adaptive immune cells, the enhancement of activation and proliferation of tumor-specific cytotoxic T lymphocytes, and the attenuation of the immunosuppressive tumor microenvironment by reducing the activity of regulatory T cells and myeloid-derived suppressor cells. Both preclinical investigations and emerging clinical data in prostate cancer models highlight HIFU's potential to modulate the immune system, as evidenced by increased infiltration of effector immune cells, elevated levels of pro-inflammatory cytokines, and improved responsiveness to immune checkpoint inhibitors. HIFU induces immunogenic cell death, leading to the release of tumor antigens and danger signals that activate dendritic cells and facilitate cross-presentation to cytotoxic T cells. Additionally, FUS ablation reduces immunosuppressive cells and increases infiltration of CD8<sup>+</sup> T cells into the tumor, reshaping the tumor microenvironment. By priming the immune system while overcoming immunosuppression, combining FUS with other immunotherapies like checkpoint inhibitors and cancer vaccines holds promise for synergistic anti-tumor effects. Despite challenges in optimizing parameters and identifying suitable patients, FUS represents a novel frontier by modulating the tumor microenvironment and enhancing anti-tumor immunity through a non-invasive approach.</p>","PeriodicalId":48852,"journal":{"name":"Archivos Espanoles De Urologia","volume":"77 4","pages":"322-330"},"PeriodicalIF":0.6000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of High Intensity Focused Ultrasound (HIFU) on Tumor-Specific Immune Responses of Prostate Cancer.\",\"authors\":\"Wei Chen, Lina He, Haoran Huang, Xiang Zeng, Guangqing Fu, Yi Liu, Yong Liang\",\"doi\":\"10.56434/j.arch.esp.urol.20247704.44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>High intensity focused ultrasound (HIFU), also referred to as focused ultrasound surgery (FUS), has garnered recent attention as a non-invasive therapeutic strategy for prostate cancer. It utilizes focused acoustic energy to achieve localized thermal ablation, while also potentially exerting immunomodulatory effects. This review aims to elucidate the mechanisms underlying how HIFU influences tumor-specific immune responses in prostate cancer. These mechanisms include the release of tumor-associated antigens and damage-associated molecular patterns, the activation of innate immune cells, the facilitation of antigen presentation to adaptive immune cells, the enhancement of activation and proliferation of tumor-specific cytotoxic T lymphocytes, and the attenuation of the immunosuppressive tumor microenvironment by reducing the activity of regulatory T cells and myeloid-derived suppressor cells. Both preclinical investigations and emerging clinical data in prostate cancer models highlight HIFU's potential to modulate the immune system, as evidenced by increased infiltration of effector immune cells, elevated levels of pro-inflammatory cytokines, and improved responsiveness to immune checkpoint inhibitors. HIFU induces immunogenic cell death, leading to the release of tumor antigens and danger signals that activate dendritic cells and facilitate cross-presentation to cytotoxic T cells. Additionally, FUS ablation reduces immunosuppressive cells and increases infiltration of CD8<sup>+</sup> T cells into the tumor, reshaping the tumor microenvironment. By priming the immune system while overcoming immunosuppression, combining FUS with other immunotherapies like checkpoint inhibitors and cancer vaccines holds promise for synergistic anti-tumor effects. Despite challenges in optimizing parameters and identifying suitable patients, FUS represents a novel frontier by modulating the tumor microenvironment and enhancing anti-tumor immunity through a non-invasive approach.</p>\",\"PeriodicalId\":48852,\"journal\":{\"name\":\"Archivos Espanoles De Urologia\",\"volume\":\"77 4\",\"pages\":\"322-330\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archivos Espanoles De Urologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.56434/j.arch.esp.urol.20247704.44\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos Espanoles De Urologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.56434/j.arch.esp.urol.20247704.44","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

高强度聚焦超声(HIFU),又称聚焦超声手术(FUS),作为一种治疗前列腺癌的无创疗法,近年来备受关注。它利用聚焦声波能量实现局部热消融,同时还可能产生免疫调节作用。本综述旨在阐明 HIFU 如何影响前列腺癌肿瘤特异性免疫反应的机制。这些机制包括释放肿瘤相关抗原和损伤相关分子模式、激活先天性免疫细胞、促进抗原呈递给适应性免疫细胞、增强肿瘤特异性细胞毒性T淋巴细胞的活化和增殖,以及通过降低调节性T细胞和髓源性抑制细胞的活性来减轻免疫抑制性肿瘤微环境。前列腺癌模型的临床前研究和新出现的临床数据都强调了 HIFU 调节免疫系统的潜力,这表现在效应免疫细胞浸润增加、促炎细胞因子水平升高以及对免疫检查点抑制剂的反应性提高。HIFU 可诱导免疫原性细胞死亡,导致肿瘤抗原和危险信号的释放,从而激活树突状细胞并促进与细胞毒性 T 细胞的交叉呈递。此外,FUS 消融减少了免疫抑制细胞,增加了 CD8+ T 细胞对肿瘤的浸润,重塑了肿瘤微环境。通过在克服免疫抑制的同时激活免疫系统,FUS有望与检查点抑制剂和癌症疫苗等其他免疫疗法相结合,产生协同抗肿瘤效果。尽管在优化参数和确定合适患者方面存在挑战,但 FUS 通过非侵入性方法调节肿瘤微环境并增强抗肿瘤免疫力,代表了一个新的前沿领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Impact of High Intensity Focused Ultrasound (HIFU) on Tumor-Specific Immune Responses of Prostate Cancer.

High intensity focused ultrasound (HIFU), also referred to as focused ultrasound surgery (FUS), has garnered recent attention as a non-invasive therapeutic strategy for prostate cancer. It utilizes focused acoustic energy to achieve localized thermal ablation, while also potentially exerting immunomodulatory effects. This review aims to elucidate the mechanisms underlying how HIFU influences tumor-specific immune responses in prostate cancer. These mechanisms include the release of tumor-associated antigens and damage-associated molecular patterns, the activation of innate immune cells, the facilitation of antigen presentation to adaptive immune cells, the enhancement of activation and proliferation of tumor-specific cytotoxic T lymphocytes, and the attenuation of the immunosuppressive tumor microenvironment by reducing the activity of regulatory T cells and myeloid-derived suppressor cells. Both preclinical investigations and emerging clinical data in prostate cancer models highlight HIFU's potential to modulate the immune system, as evidenced by increased infiltration of effector immune cells, elevated levels of pro-inflammatory cytokines, and improved responsiveness to immune checkpoint inhibitors. HIFU induces immunogenic cell death, leading to the release of tumor antigens and danger signals that activate dendritic cells and facilitate cross-presentation to cytotoxic T cells. Additionally, FUS ablation reduces immunosuppressive cells and increases infiltration of CD8+ T cells into the tumor, reshaping the tumor microenvironment. By priming the immune system while overcoming immunosuppression, combining FUS with other immunotherapies like checkpoint inhibitors and cancer vaccines holds promise for synergistic anti-tumor effects. Despite challenges in optimizing parameters and identifying suitable patients, FUS represents a novel frontier by modulating the tumor microenvironment and enhancing anti-tumor immunity through a non-invasive approach.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archivos Espanoles De Urologia
Archivos Espanoles De Urologia UROLOGY & NEPHROLOGY-
CiteScore
0.90
自引率
0.00%
发文量
111
期刊介绍: Archivos Españoles de Urología published since 1944, is an international peer review, susbscription Journal on Urology with original and review articles on different subjets in Urology: oncology, endourology, laparoscopic, andrology, lithiasis, pediatrics , urodynamics,... Case Report are also admitted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信